Citadel Advisors
FBT icon

Citadel Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Citadel Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$34K – 13261
2025
Q1 		$34K Buy
+200
New +$34.7K ﹤0.01% 12696
2023
Q4 		– Sell
-200
Closed -$29.3K – 14559
2023
Q3 		$29.3K Buy
+200
New +$30.5K ﹤0.01% 12286
2023
Q2 		– Sell
-2,000
Closed -$310K – 14578
2023
Q1 		$310K Buy
+2,000
New +$314K ﹤0.01% 9312
2022
Q1 		– Sell
-2,300
Closed -$373K – 13877
2021
Q4 		$373K Buy
+2,300
New +$372K ﹤0.01% 10412
2021
Q2 		– Sell
-6,400
Closed -$1.03M – 13877
2021
Q1 		$1.03M Buy
+6,400
New +$1.1M ﹤0.01% 8038
2020
Q1 		– Sell
-2,300
Closed -$342K – 9749
2019
Q4 		$342K Buy
2,300
+600
+35% +$82.4K ﹤0.01% 7389
2019
Q3 		$210K Sell
1,700
-1,200
-41% -$160K ﹤0.01% 8091
2019
Q2 		$408K Sell
2,900
-2,300
-44% -$317K ﹤0.01% 7116
2019
Q1 		$784K Buy
+5,200
New +$748K ﹤0.01% 6021
2018
Q4 		– Sell
-2,100
Closed -$333K – 9291
2018
Q3 		$333K Sell
2,100
-1,600
-43% -$242K ﹤0.01% 7398
2018
Q2 		$518K Sell
3,700
-1,900
-34% -$261K ﹤0.01% 6302
2018
Q1 		$744K Buy
+5,600
New +$765K ﹤0.01% 5245
2017
Q3 		– Sell
-6,000
Closed -$684K – 7658
2017
Q2 		$684K Buy
+6,000
New +$645K ﹤0.01% 4664
2017
Q1 		– Sell
-6,500
Closed -$591K – 7605
2016
Q4 		$591K Sell
6,500
-2,400
-27% -$225K ﹤0.01% 4643
2016
Q3 		$887K Buy
+8,900
New +$873K ﹤0.01% 3998

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Citadel Advisors's FBT Position: Q4 2025 in Review

Citadel Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2025, closing a stake of 26,102 shares — an estimated $5.22M sold.

Citadel Advisors first reported a position in FBT in Q4 2014 and held it in 40 quarters. The position peaked at $9.4M in Q3 2015. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

  • Citadel Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 26,102 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $5.22M.
  • Citadel Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 40 quarters.
  • Citadel Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.4M in Q3 2015.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.